{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:52:19Z","timestamp":1783029139348,"version":"3.54.6"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>In-transit metastasis from cutaneous squamous cell carcinoma (SCC) is an uncommon form of metastasis through lymphatics and occurs more commonly in immunosuppressed patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To identify cases of in-transit SCC and determine patient characteristics, tumor features, management, and prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS AND MATERIALS<\/jats:title>\n            <jats:p>A multicenter case series treated by Australian and New Zealand clinicians.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>In 31 patients, median age was 72 years (range 52\u201399) and 68% were immunocompetent. Tumors occurred on the head and neck in 94% of cases, with 71% of all tumors occurring on the scalp, forehead, or temple. The median time to presentation with in-transit SCC from treatment of the initial tumor was 5 months. Management included surgery (94%), radiotherapy (77%), chemotherapy (10%), and reduction of immunosuppression (3%). Median follow-up was 12 months. Overall survival at 3 and 5 years were 27% and 13%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>In-transit metastases are described in 31 patients, of whom the majority was immunocompetent. The scalp, forehead, and temple were the most common sites. New clinical and histological diagnostic criteria are proposed. Prognosis was poor with 5-year survival of 13%. Recommended management is a combination of surgery and adjuvant radiotherapy. Reduction of any iatrogenic immunosuppression should be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000000864","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T13:09:08Z","timestamp":1472908148000},"page":"1285-1292","source":"Crossref","is-referenced-by-count":30,"title":["In-Transit Metastasis From Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Joyce H.Y.","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Dermatology, Royal Adelaide Hospital, Adelaide, Australia;"},{"name":"Department of Medicine, Flinders Medical Center, Bedford Park, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Adelaide Hospital, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Veness","sequence":"additional","affiliation":[{"name":"Head and Neck Cancer Service, Westmead Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Estall","sequence":"additional","affiliation":[{"name":"PeterMac Cancer Center, East Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hong","sequence":"additional","affiliation":[{"name":"Central Clinical School, University of Sydney, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Borg","sequence":"additional","affiliation":[{"name":"Adelaide Radiotherapy Center, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"James","sequence":"additional","affiliation":[{"name":"Adelaide Pathology Partners, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ibbetson","sequence":"additional","affiliation":[{"name":"Surgical Pathology Division, SA Pathology, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Ooi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Adelaide Hospital, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Weightman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Queen Elizabeth Hospital, Woodville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McColl","sequence":"additional","affiliation":[{"name":"John Flynn Hospital, Tugun, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hamann","sequence":"additional","affiliation":[{"name":"Mid North Coast Dermatology, Port Macquarie, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Grieve","sequence":"additional","affiliation":[{"name":"Dermatology SA, Norwood, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Ozluer","sequence":"additional","affiliation":[{"name":"Southport Dermatology, Southport, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Salmon","sequence":"additional","affiliation":[{"name":"Dermatologic Surgery Unit, Skin Cancer Institute, Tauranga, Bay of Plenty, New Zealand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Nikitins","sequence":"additional","affiliation":[{"name":"Sach Day Surgery, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugesh","family":"Caplash","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Royal Adelaide Hospital, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Marshall","sequence":"additional","affiliation":[{"name":"Adelaide Plastic Surgery Associates, Adelaide, Australia;"},{"name":"Department of Plastic and Reconstructive Surgery, Flinders Medical Center, Bedford Park, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Edwards","sequence":"additional","affiliation":[{"name":"Adelaide Plastic Surgery Associates, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Patterson","sequence":"additional","affiliation":[{"name":"West Lakes Day Surgery, West Lakes, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selva","sequence":"additional","affiliation":[{"name":"South Australian Institute of Ophthalmology, University of Adelaide, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamala C.","family":"Huilgol","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Adelaide Hospital, Adelaide, Australia;"},{"name":"Adelaide Skin and Eye Center, Kent Town, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5694\/j.1326-5377.2006.tb00086.x","article-title":"Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985","volume":"184","author":"Staples","year":"2006","journal-title":"Med J Aust"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ejca.2012.01.003","article-title":"Trends of cutaneous squamous cell carcinoma in The Netherlands: increased incidence rates, but stable relative survival and mortality 1989\u20132008","volume":"48","author":"Hollestein","year":"2012","journal-title":"Eur J Cancer"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jso.23731","article-title":"The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma\u2013implications on the T-classification system","volume":"110","author":"Brougham","year":"2014","journal-title":"J Surg Oncol"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R8-20230814","first-page":"651","article-title":"In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients","volume":"30","author":"Carucci","year":"2004","journal-title":"Dermatol Surg"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.139.3.301","article-title":"Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study","volume":"139","author":"Martinez","year":"2003","journal-title":"Arch Dermatol"},{"key":"R10-20230814","first-page":"1415","article-title":"Subcutaneous nodules on the face: acantholytic in-transit cutaneous metastasis","volume":"30","author":"Copcu","year":"2004","journal-title":"Dermatol Surg"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archderm.1985.01660080095023","article-title":"Epidermotropic metastatic squamous cell carcinoma. Report of two cases showing histologic continuity between epidermis and metastasis","volume":"121","author":"Weidner","year":"1985","journal-title":"Arch Dermatol"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.143.7.889","article-title":"Treatment of recurrent squamous cell carcinoma of the skin with cetuximab","volume":"143","author":"Bauman","year":"2007","journal-title":"Arch Dermatol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2230.2008.02967.x","article-title":"Multiple in-transit cutaneous metastases from a primary cutaneous squamous cell carcinoma","volume":"34","author":"Wain","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.4081\/dr.2011.e57","article-title":"Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp","volume":"3","author":"Wollina","year":"2011","journal-title":"Dermatol Reports"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0019-5154.97674","article-title":"In-transit metastases from squamous cell carcinoma penis","volume":"57","author":"Padmavathy","year":"2012","journal-title":"Indian J Dermatol"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2310\/7750.2014.14047","article-title":"In-transit metastasis from primary cutaneous squamous cell carcinoma in a nonimmunosuppressed patient","volume":"19","author":"Kocaturk","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5021\/ad.2015.27.4.442","article-title":"Marjolin's ulcer presenting with in-transit metastases: a case report and literature review","volume":"27","author":"Altunay","year":"2015","journal-title":"Ann Dermatol"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"543","DOI":"10.5694\/mja13.00214","article-title":"Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia","volume":"201","author":"Neoh","year":"2014","journal-title":"Med J Aust"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0151-9638(05)79280-2","article-title":"Treatment of cutaneous metastases of a squamous cell carcinoma of the leg with topical miltefosine [in French]","volume":"132","author":"Mahieu-Renard","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjps.1998.3050","article-title":"The pathogenesis of local recurrence of melanoma at the primary excision site","volume":"52","author":"Heenan","year":"1999","journal-title":"Br J Plast Surg"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hed.20576","article-title":"Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes","volume":"29","author":"Veness","year":"2007","journal-title":"Head Neck"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.03.039","article-title":"High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: a literature review","volume":"73","author":"Navarrete-Dechent","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MOO.0b013e32832924e0","article-title":"Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes","volume":"17","author":"Bumpous","year":"2009","journal-title":"Curr Opinion Otolaryngol Head Neck Surg"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00005537-200310000-00031","article-title":"Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy","volume":"113","author":"Veness","year":"2003","journal-title":"Laryngoscope"},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"563829","DOI":"10.1155\/2012\/563829","article-title":"A review of radiotherapy for merkel cell carcinoma of the head and neck","volume":"2012","author":"Lee","year":"2012","journal-title":"J Skin Cancer"},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MOO.0b013e3282f44879","article-title":"Merkel cell carcinoma: a review of management","volume":"16","author":"Veness","year":"2008","journal-title":"Curr Opinion Otolaryngol Head Neck Surg"},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"III222","DOI":"10.1161\/circ.102.suppl_3.III-222","article-title":"Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy","volume":"102","author":"Caforio","year":"2000","journal-title":"Circulation"},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archderm.140.9.1079","article-title":"Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients","volume":"140","author":"Fortina","year":"2004","journal-title":"Arch Dermatol"},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.2005.02.155","article-title":"Mortality risk from squamous cell skin cancer","volume":"23","author":"Clayman","year":"2005","journal-title":"J Clinical Oncol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201611000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:15:57Z","timestamp":1692040557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201611000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000000864","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}